University of Minnesota. Driven to Discover.
(CIDRAP News) – An eagerly anticipated trial of a tuberculosis (TB) vaccine candidate in South African infants yielded disappointing efficacy results, according to study published today in The Lancet.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.